Methods and systems for restoring cell therapy manufacturing

By using state machines and decision trees, and utilizing external systems to store states and variables, the cell therapy manufacturing process can be restored, solving the problem of efficient recovery after interruption and improving the reliability and efficiency of the process.

CN123125315APending Publication Date: 2026-11-17GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202580029202.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2024-04-22
Filing Date
2025-04-01
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Current technologies lack efficient solutions for resuming interrupted cell therapy manufacturing processes, leading to potentially significant losses.

Method used

By employing state machines and decision trees, the state and variables are stored in an external system, and the cell manufacturing process is restored using the processor, including pause and resume instructions. This ensures that conditions are maintained in the system's safe mode and restores the manufacturing process based on the saved state and variables.

Benefits of technology

It enables efficient recovery after interruptions in cell therapy manufacturing, ensuring system safety and improving process reliability and efficiency while reducing losses.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123125315A_ABST
    Figure CN123125315A_ABST
Patent Text Reader

Abstract

A method is provided for resuming a biological processing system configured to manufacture cells for cell therapy. The method, executed by one or more processors and using the biological processing system, includes: executing one or more first sub-state machines of a plurality of sub-state machines for manufacturing the cells; storing a plurality of states in an external system; pausing the manufacturing of the cells based on a detected event; retrieving a saved state from the external system based on user input instructing the resumption of the manufacturing of the cells; comparing the saved state with the state machines to determine, from the one or more first sub-state machines, the sub-state machine most recently executed by the biological processing system before the suspension of the manufacturing of the cells; and resuming the manufacturing of the cells based on the determined sub-state machine.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This disclosure relates to a system recovery protocol configured to restore cell therapy manufacturing within a bioprocessing system. This protocol is applicable to bioprocessing applications implementing system recovery protocols. Background Technology

[0002] Various medical therapies involve the extraction, culture, and expansion of cells used in downstream treatment processes. For example, cell therapy techniques include chimeric antigen receptor (CAR) T-cell therapy. Typically, CAR T-cell therapy redirects a patient's T cells to specifically target and destroy tumor cells. The basic principle of CAR T-cell design involves recombinant receptors that combine antigen-binding and T-cell activation functions. A general premise of CAR T-cell therapy is the artificial generation of T cells that target markers found on cancer cells. Scientists can take T cells from a human body, genetically modify them, and then return them to the patient so that they attack cancer cells. CAR T cells can be derived from the patient's own blood (autologous) or from another healthy donor (allogeneic).

[0003] The first step in CAR T-cell production involves using apheresis (e.g., leukoablation) to remove blood from a patient and separate leukocytes. After a sufficient number of leukocytes have been collected, the apheresis product is enriched for T cells, which involves depleting unwanted cell types. Then, if needed, a subset of T cells with specific biomarkers can be isolated from the enriched subset using specific antibody conjugates or biomarkers.

[0004] After the target T cells are isolated, these cells are activated in a specific environment where they can proliferate actively. For example, cells can be activated using magnetic beads coated with monoclonal antibodies against differentiation cluster 3 (anti-CD3) / anti-differentiation cluster 28 (anti-CD28) or cell-based artificial antigen-presenting cells (aAPCs), which can be removed from the culture using magnetic separation. The T cells are then transduced using the CAR gene via an integrative gamma retrovirus (RV) or a lentiviral (LV) vector. The viral vector attaches to the patient cells using a viral mechanism, and upon entry into the cells, the vector introduces genetic material in the form of RNA. In the case of CAR-T cell therapy, this genetic material encodes a CAR. The RNA is reverse transcribed into DNA and permanently integrated into the genome of the patient cells; this allows CAR expression to be maintained as the cells divide and grow in large numbers in the bioreactor. The CAR is then transcribed and translated by the patient cells, and the CAR is expressed on the cell surface.

[0005] After T cells are activated and transduced with a viral vector encoding a CAR, the cells are expanded to a large quantity in a bioreactor to achieve the desired cell density. After expansion, the cells are collected, washed, concentrated, and formulated for infusion into patients.

[0006] Existing systems and methods for manufacturing cell therapy products typically involve numerous complex operations spanning extended production cycles (spanning days or weeks). Interruptions to the manufacturing process can potentially lead to significant losses. However, current technologies lack solutions for efficiently resuming interrupted processes. Summary of the Invention

[0007] A first aspect of this disclosure provides a method for resuming a bioprocessing system configured to manufacture cells for cell therapy, the method comprising: executing one or more first sub-state machines of a plurality of sub-state machines for manufacturing the cells by one or more processors and using the bioprocessing system, wherein each of the plurality of sub-state machines is associated with a node within a state machine, wherein the state machine includes a decision tree having a plurality of branches and a plurality of nodes; storing a plurality of states by the one or more processors in an external system, wherein each of the plurality of states is saved to the external system based on the completion of a state within a first sub-state machine for manufacturing the cells from the one or more first sub-state machines; pausing the manufacturing of the cells by the one or more processors based on a detected event; retrieving a saved state from the external system by the one or more processors based on receiving user input instructing the resumption of the manufacturing of the cells, wherein the saved state is the last state saved to the external system; comparing the saved state with the state machine by the one or more processors to determine, from the one or more first sub-state machines, the sub-state machine most recently executed by the bioprocessing system before pausing the manufacturing of the cells; and resuming the manufacturing of the cells by the one or more processors based on the determined sub-state machine.

[0008] According to an embodiment of the first aspect, each of the plurality of states stored in the external system is associated with a state identifier (ID). Comparing a saved state with the state machine to determine the sub-state machine includes: comparing the state ID of the saved state with the state machine to determine from the plurality of sub-state machines a sub-state machine having a state with the same state ID as the saved state; and determining the sub-state machine based on the comparison result.

[0009] According to an embodiment of the first aspect, the method further includes: storing by the one or more processors and in the external system a plurality of variables associated with the operating conditions of the biological processing system, wherein a subset of the plurality of variables is saved to the external system based on the completion of the sub-state machine for manufacturing the cell from the one or more first sub-state machines, and wherein the restoration of the manufacturing of the cell is further based on the use of the subset of the plurality of variables associated with the determined sub-state machine.

[0010] According to the implementation of the first aspect, the execution of the sub-state machine from the one or more first sub-state machines begins with the default value of the subset of the plurality of variables, and wherein the subset of the plurality of variables is periodically updated during the execution of the sub-state machine from the one or more first sub-state machines.

[0011] According to an embodiment of the first aspect, the method further includes: receiving a plurality of first user inputs indicating a plurality of parameters associated with manufacturing the cell; and determining the one or more first sub-state machines based on the plurality of parameters.

[0012] According to an embodiment of the first aspect, suspending cell manufacturing based on detecting the event includes: providing one or more first instructions to one or more devices within the biological processing system to initiate a safe mode. Resuming cell manufacturing includes: providing one or more second instructions to the one or more devices within the biological processing system based on a determined sub-state machine to stop the safe mode.

[0013] According to an embodiment of the first aspect, the biological treatment system maintains certain conditions in the safety mode to preserve the cells within the biological treatment system, and provides one or more first instructions to the one or more devices within the biological treatment system to initiate the safety mode, including one or more of the following: maintaining the temperature and carbon dioxide (CO2) level within the biological treatment system; closing one or more pinch valves (PV); stopping one or more pumps; restoring the tilting platform within the biological treatment system to a horizontal position; engaging the disposable kit (DK); activating the red light; or opening one or more interlocking devices.

[0014] According to an embodiment of the first aspect, restoring the manufacturing of the cell includes: determining a plurality of restoration processes based on a determined sub-state machine; executing the plurality of restoration processes; and after executing the plurality of restoration processes, executing a subsequent sub-state machine from the plurality of sub-state machines to restore the manufacturing of the cell.

[0015] According to an embodiment of the first aspect, the external system is a removable storage device.

[0016] According to an embodiment of the first aspect, the external system is a network attached storage device (NAS), and storing the plurality of states includes providing the plurality of states to the NAS via a network by the one or more processors.

[0017] According to an embodiment of the first aspect, resuming the manufacture of the cell based on the determined sub-state machine includes: providing instructions to a second biological processing system to resume the manufacture of the CAR T cell based on the determined sub-state machine, wherein the second biological processing system is separate from the biological processing system executing the one or more first sub-state machines.

[0018] According to an embodiment of the first aspect, the external system includes a database, and wherein the plurality of states are saved to the database in the external system based on a sequence of completing each of the plurality of sub-state machines.

[0019] According to the first aspect of the implementation, the cell therapy is a chimeric antigen receptor (CAR) T cell therapy.

[0020] A second aspect of this disclosure provides a non-transitory computer-readable medium having stored thereon instructions for resuming a biological processing system configured to manufacture cells for cell therapy, wherein the instructions, when executed by one or more processors, cause the one or more processors to perform the following operations: using the biological processing system to execute one or more first sub-state machines of a plurality of sub-state machines for manufacturing the cells, wherein each of the plurality of sub-state machines is associated with a node within a state machine, wherein the state machine includes a decision tree having multiple branches and multiple nodes; storing a plurality of states in an external system, wherein each of the plurality of states is saved to the external system based on the completion of a sub-state machine for manufacturing the cells from the one or more first sub-state machines; pausing the manufacturing of the cells based on a detected event; retrieving a saved state from the external system based on receiving user input instructing the resumption of the manufacturing of the cells, wherein the saved state is the last state saved to the external system; comparing the saved state with the state machine to determine, from the one or more first sub-state machines, the sub-state machine most recently executed by the biological processing system before pausing the manufacturing of the cells; and resuming the manufacturing of the cells based on the determined sub-state machine.

[0021] According to an embodiment of the second aspect, each of the plurality of states stored in the external system is associated with a state identifier (ID). Comparing a saved state with the state machine to determine the sub-state machine includes: comparing the identifier associated with the saved state with the state machine to determine from the plurality of sub-state machines a sub-state machine having a state ID that has the same state ID as the saved state; and determining the sub-state machine based on the comparison result.

[0022] According to an embodiment of the second aspect, when executed by one or more processors, the instruction causes the one or more processors to further perform the following operations: storing a plurality of variables associated with the operating conditions of the biological processing system in the external system, wherein a subset of the plurality of variables is saved to the external system based on the completion of the sub-state machine for manufacturing the cell from the one or more first sub-state machines, and wherein the restoration of the manufacturing of the cell is further based on the use of the subset of the plurality of variables associated with the determined sub-state machine.

[0023] According to the second aspect of the implementation, the execution of the sub-state machine begins with the default value of the subset of the plurality of variables, and wherein the subset of the plurality of variables is periodically updated during the execution of the sub-state machine from the one or more first sub-state machines.

[0024] According to an implementation of the second aspect, when executed by one or more processors, the instructions cause the one or more processors to further perform the following operations: receive a plurality of first user inputs indicating a plurality of parameters associated with the manufacture of the cell; and determine the one or more first sub-state machines based on the plurality of parameters.

[0025] According to the second aspect of the implementation, suspending cell manufacturing based on detecting the event includes: providing one or more first instructions to one or more devices within the biological processing system to initiate a safe mode. Resuming cell manufacturing includes: providing one or more second instructions to the one or more devices within the biological processing system based on a determined sub-state machine to stop the safe mode.

[0026] According to the second aspect of the implementation, restoring the manufacturing of the cell includes: determining a plurality of restoration processes based on the determined sub-state machines; executing the plurality of restoration processes; and after executing the plurality of restoration processes, executing a subsequent sub-state machine from the plurality of sub-state machines to restore the manufacturing of the cell.

[0027] A third aspect of this disclosure provides a system for resuming a biological processing system configured to manufacture cells for cell therapy. The system includes: a first device communicating with one or more processors; and the one or more processors configured to: execute one or more first sub-state machines of a plurality of sub-state machines for manufacturing the cells using the biological processing system, wherein each of the plurality of sub-state machines is associated with a node from a state machine, wherein the state machine includes a decision tree having multiple branches and multiple nodes; store a plurality of states in the first device, wherein each of the plurality of states is saved to the first device based on the completion of a sub-state machine for manufacturing the cells from the one or more first sub-state machines; suspend the manufacturing of the cells based on a detected event; retrieve a saved state from the first device based on receiving user input instructing the resumption of the manufacturing of the cells, wherein the saved state is the last state saved to the first device; compare the saved state with the state machine to determine from the one or more first sub-state machines the most recently executed sub-state machine by the biological processing system before suspending the manufacturing of the cells; and resume the manufacturing of the cells based on the determined sub-state machine.

[0028] All the examples and features mentioned in this article can be combined in any technically possible way. Attached Figure Description

[0029] The subject matter will be described in more detail below with reference to exemplary figures, but not limited to these examples. All features described and / or illustrated herein may be used alone or in different combinations. The features and advantages of various examples will become apparent from the following detailed description with reference to the accompanying figures, which illustrate the following: Figure 1A This is a simplified block diagram depicting an exemplary environment according to examples of this disclosure.

[0030] Figure 1B This is a schematic diagram of an exemplary biological treatment system according to an example of this disclosure.

[0031] Figure 1C This is a block diagram of an exemplary control system according to an example of this disclosure.

[0032] Figure 2 It is a simplified diagram depicting an exemplary state machine according to one or more examples of this disclosure.

[0033] Figure 3 This is an exemplary process for restoring a biological treatment system according to one or more examples of this disclosure.

[0034] Figure 4 This is an exemplary workflow with interruption events according to one or more examples of this disclosure.

[0035] Figure 5 It is a simplified block diagram depicting an exemplary recovery process according to one or more examples of this disclosure.

[0036] Figure 6 This is an exemplary workflow for restoring a state machine according to one or more examples of this disclosure.

[0037] Figure 7 This is an exemplary workflow for restoring a manufacturing process according to one or more examples of this disclosure.

[0038] Figure 8A An exemplary environment based on examples of this disclosure is depicted.

[0039] Figure 8B It is for reference. Figure 8A An exemplary workflow for restoring an application.

[0040] Figure 9A An exemplary environment based on examples of this disclosure is depicted.

[0041] Figure 9B It is for reference. Figure 9AAn exemplary workflow for restoring an application.

[0042] It should be understood that the accompanying drawings are not necessarily drawn to scale, and the disclosed embodiments are sometimes shown graphically and in partial views. In some cases, details that are not necessary for understanding this disclosure or that make other details difficult to perceive may have been omitted. It should be understood that this disclosure is not limited to the specific embodiments illustrated herein. Detailed Implementation

[0043] Examples of this application will now be described more fully below with reference to the accompanying drawings, which show some, but not all, examples of this application. In fact, this application may be exemplified in different forms and should not be construed as limited to the examples set forth herein; rather, these examples are provided to enable this application to meet applicable legal requirements. Where possible, unless expressly stated otherwise, any term expressed herein in the singular is also intended to include the plural form, and vice versa. Furthermore, as used herein, the terms “a” and / or “an” should mean “one or more,” even though the phrase “one or more” is also used herein. Additionally, when something is referred to herein as being “based on” another thing, it may also be based on one or more other things. In other words, unless expressly indicated otherwise, as used herein, “based on” means “at least partially based on” or “at least partially based on”.

[0044] This article discloses systems, methods, and computer program products that provide a biological processing system for manufacturing cells (e.g., therapeutic cells) for cell therapy. Cell (or cell-based) therapy (CT) is a therapy that transfers autologous or allogeneic cell material into a patient to achieve the effects of a drug, such as replacing or repairing damaged tissues and / or cells. Figure 1A This is a simplified block diagram depicting an exemplary environment according to an example of this disclosure. Environment 100 includes a first biological treatment system 10, an external system 20, and an optional second biological treatment system 30.

[0045] The first biological processing system 10 (biological processing system 10) includes various hardware and software components for performing the manufacturing processes disclosed in this disclosure. Reference will be made below. Figure 1B A detailed description of an example of a biological processing system configured for manufacturing cell immunotherapy.

[0046] The biological treatment system 10 can operate under the control of a control system, which may include a centralized control unit and / or one or more independent control units. The control system and / or control units may be integrated into, connected to, and communicate with the biological treatment system and other entities within the environment 100 (e.g., external system 20 and / or second biological treatment system 30). The control system and / or control units may include one or more processors (such as one or more central processing units (CPUs), controllers, and / or logic units) that execute computer-executable instructions for performing the functions, processes, and / or methods described herein. Reference will be made below. Figure 1C Provide a detailed description of an example of a control system. The controller device may include some or all of the components within the control system.

[0047] Although entities within environment 100 may be described below and / or depicted as singular entities in the accompanying drawings, it should be understood that the entities and functionality discussed herein may be implemented by and / or include one or more entities. For example, biological processing systems 10 / 30 and / or external systems 20 may include multiple modules, devices, systems, and / or servers distributed across multiple different geographical locations and communicating with each other using direct connections and / or suitable networks.

[0048] External system 20 communicates with biological processing system 10 and is configured to cooperate with biological processing system 10 in order to recover appropriate information in order to recover biological processing system 10 from interruption events.

[0049] Additionally and / or alternatively, the external system 20 may communicate with the second biological processing system 30 and be configured to cooperate with the second biological processing system 30 to resume interrupted processes on the biological processing system 10. For example, the external system 20 may resume interrupted processes on the second biological processing system 30.

[0050] In some examples, the control system may instruct the biological processing system 10 to continuously or periodically save, store, upload, modify, and / or update the set of variable values ​​and / or parameter sets corresponding to the process in the external system 20 during its operation. Furthermore, upon process completion, the control system may instruct the biological processing system 10 to store relevant status values ​​in the external system 20 to record the completed process. In the event of an interruption, the control system may retrieve the stored status information from the external system 20 to determine the current state of the biological processing system 10, its previous completed state, and / or to resume the steps / operations of the manufacturing process on the biological processing system 10 or another biological processing system 30.

[0051] In some examples, external system 20 can be any type of removable data storage system that allows a user to insert or remove storage media from biological processing system 10 or any other processing system connected to biological processing system 10. Examples of removable storage systems include, but are not limited to, universal serial bus (USB) flash drives, external hard drives, secure digital (SD) cards, microSD cards, optical discs (e.g., CD, DVD, or Blu-ray discs), portable solid-state drives (SSDs), etc.

[0052] In some cases, external system 20 may include a network attached storage device (NAS). A NAS is a dedicated file storage device or server connected to a network, providing centralized data storage and access for multiple users and heterogeneous clients. External system 20 may be part of a NAS system designed to function as a shared storage resource accessible via any suitable type of network.

[0053] In some variations, entities within environment 100 (such as biological processing system 10, external system 20, and / or biological processing system 30) can communicate with other devices and / or systems within environment 100 via a network. The network can be a Global Area Network (GAN), Wide Area Network (WAN), Local Area Network (LAN), or any other type of network or combination thereof, such as the Internet. The network can provide wired communication, wireless communication, or a combination of wired and wireless communication between entities within environment 100.

[0054] It should be understood that Figure 1A The exemplary environment depicted herein is merely an example, and the principles discussed herein may also be applied to other situations (e.g., other types of devices, systems, and network configurations). For example, the functionality of the biological processing system 10 / 30 and / or the external system 20 may be separated into several different entities.

[0055] Figure 1B This is a schematic diagram of an exemplary biological treatment system according to examples of this disclosure. Figure 1B The biological treatment system shown can be embodied as follows: Figure 1A The biological treatment system 10 and / or the second biological treatment system 30 within the environment 100 depicted herein.

[0056] The bioprocessing system 10 is configured for manufacturing cell immunotherapies (e.g., autologous cell immunotherapy), wherein, for example, human blood, fluid, tissue, or cell samples are collected, and cell therapies are generated from or based on the collected samples. One type of cell immunotherapy that can be manufactured using the bioprocessing system 10 is chimeric antigen receptor (CAR) T-cell therapy, but other cell therapies may also be produced using the system 10 or aspects thereof without departing from the broader aspects of this disclosure. Figure 1B As illustrated, the manufacture of CAR T-cell therapy typically begins with the collection of a patient's blood and the isolation of lymphocytes via apheresis. Collection / apheresis can be performed in a clinical setting, and the apheresis product is then sent to a laboratory or manufacturing facility to produce CAR-T cells. Once the apheresis product is received for processing, the desired cell population (e.g., leukocytes) is enriched or isolated from the collected blood for use in the cell therapy, and target cells of interest are isolated from the initial cell mixture. The target cells of interest are then activated, genetically modified to specifically target and destroy tumor cells, and expanded to achieve the desired cell density. After expansion, the cells are harvested and a dose is formulated. The formulation is typically then cryopreserved and delivered to a clinical setting for thawing, preparation, and finally infusion into the patient.

[0057] Further reference Figure 1B The biological processing system 10 includes multiple distinct modules (e.g., subsystems), each configured to perform a specific subset of the manufacturing process in a substantially automated, functionally closed, and scalable manner. For example, the biological processing system 10 includes: a first module 110 configured to perform enrichment and separation processes; a second module 120 configured to perform activation, gene modification, and amplification processes; and a third module 130 configured to perform the collection and amplification of cell populations. In one embodiment, each module 110, 120, and 130 is communicatively coupled to a dedicated controller (e.g., a first controller 112, a second controller 122, and a third controller 132, respectively). Controllers 112, 122, and 132 are configured to provide substantially automated control over the manufacturing processes within each module. While the first module 110, the second module 120, and the third module 130 are illustrated as including dedicated controllers for controlling the operation of each module, it is contemplated that a master control system (e.g., a control system and / or control device) could be used to provide global control over the three modules. Each module 110, 120, 130 is configured to work in conjunction with other modules to form a single, coherent biological processing system 10.

[0058] By automating processes within each module, product consistency across modules is improved, and costs associated with extensive manual operations are reduced. Furthermore, each module (110, 120, 130) is largely functionally closed, which helps ensure patient safety by mitigating the risk of external contamination, ensures regulatory compliance, and helps avoid the costs associated with open systems. Additionally, each module (110, 120, 130) is scalable to support development with low patient numbers and commercial manufacturing with high patient numbers.

[0059] Further reference Figure 1BDividing the process into specific modules, each providing closed and automated biological processing, allows for efficient use of capital equipment. It should be understood that the process of amplifying the cell population to achieve the desired cell density before collection and formulation is typically the most time-consuming part of the manufacturing process, while enrichment and separation, collection and formulation, and activation and genetic modification processes are much less time-consuming. For example, the processes of cell enrichment, separation, activation, and genetic modification can occur quite rapidly, while the amplification of genetically modified cells occurs very slowly. Therefore, manufacturing cell therapy from a first sample (e.g., blood from a first patient) will proceed rapidly up to the amplification process, which requires a significant amount of time to achieve the desired cell density for collection. In a fully automated system, the entire process / system will be monopolized by the amplification equipment performing the amplification of cells from the first sample, and processing of a second sample cannot begin until the entire system is released for use. In this respect, with a fully automated biological processing system, the entire system is essentially offline and cannot be used to process a second sample until the entire cell therapy manufacturing process (from enrichment to collection / formulation) is completed on the first sample.

[0060] use Figure 1B The different modules depicted herein allow the biological processing system 10 to be configured to process multiple samples (from the same or different patients) in parallel, providing a more efficient use of capital resources. This advantage is a direct result of the specific manner in which the process is divided into three modules 110, 120, and 130, as described above.

[0061] For example, a single first module 110 and / or a single third module 130 may be used in conjunction with multiple second modules (e.g., second module 120) in a biological processing system 10 / 30 to provide parallel and asynchronous processing of multiple samples from the same or different patients. For example, a first single-absorption product from a first patient may be enriched and isolated using the first module 110 to produce an isolated first target cell population, which may then be transferred to one of the second modules (e.g., module 120) for activation, genetic modification, and amplification under the control of a controller 122. Once the first target cell population has been transferred out of the first module 110, the first module 110 can again be used to process a second single-absorption product from, for example, a second patient. The second target cell population produced in the first module 110 from a sample taken from the second patient may then be transferred to another second module for activation, genetic modification, and amplification under the control of a corresponding controller. Similarly, after the second target cell population has been transferred out of the first module 110, the first module can again be used to process a third single-absorption product from, for example, a third patient. The third target cell population produced in the first module 110 from a sample taken from a third patient can then be transferred to another second module for activation, gene modification, and amplification under the control of a corresponding controller. In this respect, for example, the amplification of CAR T cells from the first patient can occur simultaneously with the amplification of CAR T cells from the second, third, and so on. The method also allows post-processing to occur asynchronously as needed. In other words, patient cells may not all grow at the same time. Cultures may reach their final density at different times, but the multiple second modules 120 are not linked, and the third module 130 can be used as needed. Using this disclosure, although samples can be processed in parallel, they do not necessarily have to be processed in batches. The amplification of cell populations from the second modules can also be accomplished using a single third module 130 when each amplified cell population is ready for collection.

[0062] Therefore, by separating the activation, gene modification, and amplification processes (which are the most time-consuming and share certain operational requirements and / or require similar culture conditions) into independent, automated, and functionally closed modules, other system equipment for enrichment, separation, collection, and formulation is not occupied or offline while a cell population is being amplified. Thus, the fabrication of multiple cell therapies can be carried out simultaneously, maximizing equipment and floor space utilization and improving overall process and facility efficiency. It is conceivable that additional second modules 120 can be added to the bioprocessing system 10 as needed to provide parallel processing of any number of cell populations. Therefore, the bioprocessing system of the present invention allows for plug-and-play functionality, enabling manufacturing facilities to be easily scaled up or scaled down.

[0063] In some examples, the first module 110 can be any system or device capable of producing enriched and isolated target cell populations from apheresis products derived from a patient for use in biological processes such as immunotherapy and regenerative medicine. The third module 130 can be any system or device capable of collecting and / or formulating CAR T cells or other modified cells produced by the second module 120 for infusion into a patient for use in cell immunotherapy or regenerative medicine. In some embodiments, the first module 110 and the third module 130 are similarly or identically configured such that the first module 110 can be used first for enriching and isolating cells (then transferred to the second module 120 for activation, transduction, and amplification (and in some embodiments, collection)), and then also for cell collection and / or formulation at the end of the process. In this respect, in some embodiments, the same apparatus can be used for both the front-end cell enrichment and isolation process and the back-end collection and / or formulation process.

[0064] It should be understood that Figure 1B The exemplary biological processing system depicted herein is merely an example, and the principles discussed herein may also be applied to other situations (e.g., other types of devices, systems, and configurations). For example, modules 110, 120, and 130 may be combined into a single module or distributed across multiple different entities.

[0065] Figure 1C It is a block diagram of an exemplary control system configured to control one or more entities (e.g., biological processing systems 10 / 30 and / or external systems 20) within environment 100.

[0066] The control system 150 includes one or more processors 154 (such as one or more CPUs, controllers, and / or logic units) that execute computer-executable instructions for performing the functions, processes, and / or methods described herein. In some examples, the computer-executable instructions are stored locally and accessed from a non-transitory computer-readable medium, such as storage device 160, which may be a hard disk drive or a flash drive. Read-only memory (ROM) 156 includes computer-executable instructions for initializing processor 154, while random access memory (RAM) 158 is main memory for loading and processing the instructions executed by processor 154. Network interface 162 can be connected to a wired or cellular network and to a local area network or wide area network. The control system 150 may also include a bus 152 connecting processor 154, ROM 156, RAM 158, storage device 160, and / or network interface 162. Components within the control system 150 may communicate with each other using bus 152. The components within control system 150 are merely exemplary and may not include every component, server, device, computing platform, and / or computing device within control system 150. Additionally and / or alternatively, control system 150 may also include components that may not be included in every entity of environment 100.

[0067] As previously mentioned, refer to Figure 1B The bioprocessing system 10 (e.g., each module or subsystem therein) is configured to perform multiple manufacturing processes in a substantially automated manner. Each process is associated with a pre-configured instruction set, which a processor can execute to control the bioprocessing system 10 to perform the corresponding process. In some examples, each process may consist of multiple steps, where each step is referred to as a subprocess and associated with a subset of instructions. Each process or subprocess may be defined based on initial conditions, variables during operation, and / or termination criteria for a particular process or subprocess. Instructions for processes and / or subprocesses may be generated automatically, semi-automatically, or entirely manually based on user input, default values, and / or historical data. In the following, "application" refers to the entire set of instructions associated with the manufacture of cells for cell therapy.

[0068] Furthermore, procedures or subroutines are configured to run in a specific sequence. The order in which procedures or subroutines run can be represented in any suitable form. For example, decision trees and / or finite state machines can be used to control the execution of an application according to a specific sequence, where predefined connections between nodes indicate the execution order between procedures / subroutines within the application. In the following text, for the sake of brevity, both procedures and subroutines will be referred to as "procedures".

[0069] Figure 2 This is a simplified diagram depicting an exemplary state machine according to one or more examples of this disclosure. (e.g.) Figure 2 As shown, state machine 200 includes multiple connected blocks (e.g., blocks 202, 204, 206, ...). Each block represents a sub-state machine, which can be linked to a protocol identifier (ID), such as P701 for block 204. Each sub-state machine includes a list of states that an application can transition through by executing a procedure / sub-procedure defined in the specific application. Connections between blocks indicate potential transitions between corresponding blocks in the appropriate direction. For example, in one example, state machine 200 may transition from block 202 to block 204. In another example, state machine 200 may first move from block 208 to block 212, and then return from block 212 to block 208, enabling subsequent execution of block 214.

[0070] Each state within a state machine / sub-state machine is associated with an entry condition and an exit condition, depending on the input values. For example, given a first set of input values, the application may enter a first state, while given a second set of input values, the application may exit the first state and / or enter a second state. Thus, the application can transition between states within a specific sub-state machine, or between sub-state machines within state machine 200. The state machine may follow different paths based on application inputs such as parameters, retrieved values, and / or other relevant factors. Changes in application inputs may be associated with one or more processes defined within the application. For example, the execution of a process may begin with initial conditions (e.g., aligned with an entry condition for a specific state). Changes occurring within this process may manifest as transformations of one or more variables. The completion of the process can be determined by an exit condition (e.g., corresponding to an exit condition for a specific state). Therefore, during the execution of one or more processes, the application may obtain changing inputs based on the current state of the manufacturing system (e.g., biological processing system 10). Based on these inputs, the application (e.g., state machine 200) can determine whether to move to the next state or the next sub-state machine. In other words, the execution of one or more processes by the biological processing system 10 can cause changes in its state, thereby enabling the application (e.g., state machine 200) to transition through a series of states as prescribed.

[0071] The control system (e.g., one or more processors within the system) can execute state machine 200 to control the biological processing system 10 (e.g., ...). Figure 1A or Figure 1B(As shown) The manufacturing process is executed. Information related to the execution of state machine 200 can be stored in various types of data structures. For example, the control system can store relevant information associated with the sequence of executed sub-state machines and states in a stack data structure (such as a call stack). The call stack can include a list of entries, where each entry contains identification information indicating an executed state within state machine 200. The identification information can cover a first identifier (ID) associated with a specific sub-state machine (e.g., block 204), such as a protocol ID (e.g., P701 in block 204), and a second ID indicating a specific state within the specific sub-state machine, such as a state ID. In other words, the identification information from a specific entry can be used to pinpoint a specific state of a specific sub-state machine within state machine 200. When that specific state is executed or has recently been completed, the control system can append a new entry associated with the state in the sub-state machine. In this way, the control system can store a list of entries in the call stack corresponding to the sequentially executed states in the corresponding sub-state machines. Therefore, by examining the list of entries stored in the call stack, state machine 200 can traverse the executed sub-state machines and associated states according to the previous execution order. In other words, the previous execution chain can be "replayed" under the guidance of the call stack.

[0072] In some cases, the control system may dynamically update the call stack during the execution of state machine 200, for example, by adding, deleting, or modifying one or more entries in the call stack. For example, as discussed above, addition can be facilitated by appending new entries to the call stack. The deletion of one or more entries may be associated with a movement in state machine 200 from a child node (e.g., block 212) to a parent node (e.g., block 208). For example, when state machine 200 returns from block 212 to block 208, all entries with protocol ID 752 (in block 212) may be removed. In other words, a sub-state machine that has been completed and will not be executed or passed through again may not be on the monitoring list (e.g., the dynamic call stack) because application recovery does not require passing through that particular sub-state machine. Therefore, the control system may focus on a series of interdependent sub-state machines that affect recovery to a specific state (e.g., a crash state) within a particular sub-state machine. In some variations, the list of entries in the call stack may maintain only one protocol ID and a corresponding state ID for a specific block in state machine 200. For example, when executing a sub-state machine in block 204, the sub-state machine can pass through a series of states. The control system can overwrite the state ID corresponding to the protocol ID in the call stack based on the current state of a particular sub-state machine. To this end, in the call stack, each protocol ID of a particular block within state machine 200 can be associated with a last saved state ID, which indicates the last execution state in the corresponding sub-state machine (e.g., completed, paused, or in another scenario). Additionally, when state machine 200 returns from a child node to a parent node, the last saved state ID corresponding to the sub-state machine in the parent node can be updated. This may involve appending new entries or overwriting existing entries, which may be associated with one or more additional processes that occur (e.g., calculation, measurement). Alternatively, state machine 200 can pass through sub-state machines without changing its last saved state ID.

[0073] In some variations, the control system may store one or more call stacks during the fabrication of cell immunotherapy (e.g., CAR T cell fabrication). One call stack may be dynamically updated for an "open" execution chain, which refers to a series of sub-state machines that have not yet reached an end node (e.g., block 218). Each of the other call stacks may indicate a complete execution chain from the root node (e.g., block 202) to an end node (e.g., 212). In this way, the other call stacks can be used as historical data for later evaluation / tuning of the application based on the results of the fabricated product.

[0074] Return to reference as follows Figure 2The following describes an example of executing state machine 200 and storing / updating the corresponding call stack. Each block in state machine 200 corresponds to a sub-state machine with a corresponding protocol ID, such as P301 of block 202, P701 of block 204, P704 of block 206, etc. Figure 2 As indicated in the corresponding block, each sub-state machine is associated with one or more manufacturing processes, such as "General Application" for P301 (e.g., this could be the commercial name of the application), "Kit Testing" for P701, "Activation" for P704, and so on. In some examples, each manufacturing process may include one or more sub-processes, which may be associated with state transitions within a particular sub-state machine.

[0075] In one example, state machine 200 can be executed according to the following execution chain: P301—General Application P704—Activation 750 — Reagent (in block 208) 754—Bag to Container (in block 216) P752 — Clear the pipeline (in block 218). During execution, once the sub-state machine corresponding to protocol ID P301 has completed, the control system can store protocol ID P301 and state ID 1000 onto the call stack. State ID 1000 is the last saved state ID of protocol ID P301. Then, state machine 200 transitions to the next sub-state machine with protocol ID P704. Similarly, once the sub-state machine corresponding to protocol ID P704 has completed, the control system can store protocol ID P704 and state ID 2000 onto the call stack. State ID 2000 is the last saved state ID of protocol ID P704. For this purpose, if the execution chain completes normally, the control system can store the call stack recording the executed sub-state machines (by their protocol IDs) and their corresponding last saved state IDs. However, if an interruption occurs in a specific state of the sub-state machine with protocol ID P754, state machine 200 can stop at that specific state. Therefore, the control system can store the following call stack: P301: State 1000, P704: State 2000, P750: State 3000, P754: State 1100. As indicated by the call stack, the execution of state machine 200 stops at state 1100 in sub-state machine P754. In some cases, the control system can store intermediate states within each sub-state machine into the call stack during execution. In some variations, the control system can overwrite the state ID within each sub-state machine during execution, such that the call stack stores only one protocol ID and the corresponding last saved state ID for a specific sub-state machine.

[0076] The transition from one state to the next within a sub-state machine, or from one sub-state machine to the next, depends on various factors, such as the process / sub-process to be executed and / or certain criteria, parameters, and / or other factors used to execute the process / sub-process. In some cases, the fabrication of cell immunotherapy (e.g., the fabrication of CAR T cells) may differ for different drug pipelines. For example, different drug pipelines can lead to bioprocessing systems 10 and / or applications (e.g., such as...). Figure 2 The configuration of the state machine 200 (as shown in the diagram) changes, which is facilitated, for example, by configuring appropriate user parameters associated with one or more sub-state machines in the state machine 200. Therefore, based on certain criteria, parameters, and / or other factors, the control system can be configured to execute state machine 200 in a first configuration for a first drug line and in a second configuration for a second drug line. For example, refer to... Figure 2 The example state machine 200 depicted, for a first drug line and a second drug line, allows the control system to control the biological processing system 10 to execute the sub-state machine in block 208 (e.g., P750—Reagent). Then, based on one or more factors, the control system can control the biological processing system 10 to execute the sub-state machine in block 214 for the first drug line (e.g., P759—Pre-closure), and can control the biological processing system 10 to execute the sub-state machine in block 216 for the second drug line (e.g., P754—Bag-to-Vessel). Therefore, the control system can execute state machine 200 in various sequences and / or execute different subsets of the sub-state machines for different use cases.

[0077] As detailed above, based on the protocol ID and state ID stored in the call stack, the control system can determine the exact sub-state machine (and / or the state within the sub-state machine) previously executed. Using the call stack and other suitable information (e.g., variables, parameters, and / or other factors), the control system can resume the manufacturing operation of cell immunotherapy from interruption. This will be described in further detail below.

[0078] While executing each corresponding sub-state machine, the control system can monitor relevant state information during runtime. In some cases, the control system can instruct external systems (e.g., Figure 1AThe external system 20 in the application periodically stores information such as one or more variables and / or parameters. Parameters may be related to information provided by the end user before or during application operation. The control system may determine whether to execute some or all of the processes / subprocesses defined in a particular application. Therefore, these parameters may affect subsets and sequences of states actually traversed by the application. Parameters may include, but are not limited to, target results (e.g., target volume of a target liquid bag) and / or thresholds (e.g., alarm thresholds), used as conditions for determining completion or termination at corresponding state nodes. Parameters may include fixed values ​​and / or may be modified by the end user during operation. Variables may be associated with the execution of a specific process or subprocess that evolves over time. For example, the value of a variable may indicate the progress of the biological treatment system 10 in executing a specific process or subprocess. Variables may include, but are not limited to, sensor values, calculation results, target report output paths, run IDs, duration information, etc.

[0079] Additionally and / or alternatively, upon completion of a sub-state machine, the control system may instruct an external system to store unique state information (e.g., protocol ID, state ID, etc.) of the completed sub-state machine, the next sub-state machine to be executed, and / or the currently executing sub-state machine. For example, the control system may store the protocol ID and corresponding state ID associated with the respective sub-state machine. When the control system executes a sub-state machine according to state machine 200, it may store a series of sub-state machines and corresponding states corresponding to the sequence of executed sub-state machines. The control system may retrieve the stored information from the external system and traverse the sub-state machines and corresponding states based on the connections between them.

[0080] For example, after a sub-state machine is completed (e.g., in block 208), the control system may instruct the external system 20 to store the protocol ID and state ID associated with the sub-state machine 208. For example, the control system may provide instructions to the biological processing system 10 to store the protocol ID and corresponding state ID associated with the completed sub-state machine in the external system 20. Additionally and / or alternatively, the biological processing system 10 may store the protocol ID and corresponding state ID for the completed sub-state machine in the external system 20 without receiving any instructions from the control system. In some variations, the storage of the protocol ID and corresponding state ID associated with the sub-state machine may be performed after the sub-state machine is completed. Additionally and / or alternatively, the control system may store the protocol ID and corresponding state ID associated with the currently executing sub-state machine and / or the sub-state machine to be executed next in the external system 20. In other words, the control system can store the protocol ID and corresponding state ID for the current operating state of the biological processing system 10 associated with any sub-state machine and / or state defined in state machine 200, thereby enabling the control system to determine the location within state machine 200 to resume the manufacturing process in the event of an interruption event.

[0081] In the event of an interruption, the biological processing system 10 may be paused in its current state or may be set to a specific mode (e.g., a safe mode) to preserve samples (e.g., cell samples) within the system 10. The final state of the biological processing system 10 may be stored in the external system 20 as a final saved state corresponding to a specific manufacturing process. For example, the final saved state in the external system 20 may be the most recently completed state associated with the most recently completed sub-state machine in state machine 200. For instance, after completing a sub-state machine in block 208 (e.g., corresponding to the process "reagent"), the control system may instruct the biological processing system to save the state ID associated with sub-state machine 208 to the external system 20. If an interruption event occurs before saving another state ID in the external system 20, the state ID associated with the completed sub-state machine may be the final saved state. Additionally and / or alternatively, as mentioned above, the final saved state may be another state associated with the current state, such as the next state to be executed by the biological processing system 10. As will be described below, the control system may use the final saved state to resume the manufacturing process.

[0082] like Figure 2 As depicted, certain blocks (such as blocks 212, 218, and 220) are associated with the same sub-state machine "Clear Pipeline" with protocol ID P752. In this scenario, blocks 212, 218, and 220 may correspond to the same code. Therefore, during the execution of blocks 212, 218, and 220, the control system may invoke the corresponding code under different circumstances.

[0083] As shown in the figure, state machine 200 includes multiple sub-state machines, such as sub-state machines 202-230. State machine 200 and its sub-state machines are merely exemplary. Additionally, some sub-state machines are shown as “…” to indicate that there may be additional branches and / or nodes associated with them. These additional branches and / or nodes are not shown for clarity and brevity only.

[0084] Figure 3 This is an exemplary process for restoring a biological treatment system (e.g., biological treatment system 10) according to one or more examples of this disclosure. Process 300 may be controlled by a control system (e.g., Figure 1C The control system shown is configured to control... Figure 1A The operation of the biological treatment system 10, the second biological treatment system 30, and / or the external system 20 within the environment 100 shown. In this example, the biological treatment system 10 may be configured for, as... Figure 1B The manufacturing process is shown for illustrative purposes. The control system is executable. Figure 2The state machine 200 depicted herein is used to control the operation of the biological processing system 10 / 30 and / or the external system 20. It should be understood that any of the following blocks can be executed in any suitable order, and process 300 can be executed in any suitable environment. Figure 3 The descriptions, examples, and processes described are merely exemplary, and process 300 may use other descriptions, examples, and processes to restore the biological treatment system used for a particular manufacturing process.

[0085] At block 302, the control system uses the biological processing system 10 to execute one or more first sub-state machines of a plurality of sub-state machines for manufacturing cells for cell therapy (e.g., CAR T cells). Each of the plurality of sub-state machines is associated with a node within state machine 200. State machine 200 includes a decision tree with multiple branches and multiple nodes. A sub-state machine refers to a series of nodes sequentially connected along one or more paths in the decision tree of state machine 200. One or more first sub-state machines refer to sub-state machines that have been executed and / or completed.

[0086] The control system may determine multiple sub-state machines for manufacturing based on user input. For example, the control system may receive multiple first user inputs indicating multiple parameters associated with manufacturing and determine multiple sub-state machines based on these parameters. The control system may then execute the determined sub-state machines, such as the first sub-state machine. For example, one or more parameters may be associated with information provided by the end user before or during application operation. Parameters may indicate the sequence of executing (or not executing) a part of a process (or sub-state machine), information about a target outcome (e.g., the volume of a target liquid bag), alarm thresholds, or other information. In some examples, parameters refer to “fixed” values ​​that can be modified by the end user during operation. Execution of a sub-state machine may involve changing the values ​​in one or more variables. Variables refer to data used by the corresponding process that may evolve over time. Variables may include sensor values, calculation results, output paths of target reports, run IDs, duration information, etc.

[0087] At block 304, the control system stores multiple states in external system 20. Each of the multiple states is stored in external system 20 based on the completion of a state from a first sub-state machine of state machine 200. The completion of a particular state is associated with the execution of a corresponding sub-state machine for manufacturing cells from one or more first sub-state machines. Each completed state may be associated with a unique state identifier (ID) within a particular sub-state machine. The multiple states may be stored in the database and / or memory of external system 20 based on the completion of each of the multiple sub-state machines (or a particular state therein).

[0088] For example, refer to Figure 2The control system can control the biological treatment system to execute a series of sub-state machines, such that state machine 200 passes through a sequence of nodes in the following order: P301 (e.g., node 202). P704 (e.g., node 206) P750 (e.g., node 208) P754 (e.g., node 216), etc. During operation, the control system may store the state as: state ID "1000", for node 202 with protocol ID P301; state ID "2000", for node 206 with protocol ID P704; state ID "3000", for node 208 with protocol ID P750; state ID "1100", for node 216 with protocol ID P754. During the execution of the sub-state machine, the biological processing system 10 may encounter an interruption event. In the above example, the last saved state could be state ID "1100", which is associated with node 216 with protocol ID 754.

[0089] In some cases, the control system may store multiple variables associated with the operating conditions of the biological treatment system 10. The control system may store a subset of these variables in an external system based on the completion of a sub-state machine from one or more first sub-state machines. The subset of variables may be associated with a unique state ID (e.g., the last saved state ID) and / or protocol ID corresponding to the respective sub-state machine. Therefore, the control system can retrieve the corresponding set of variables along with the corresponding state ID and / or protocol ID.

[0090] When the control system executes the corresponding sub-state machine, it can initiate the corresponding sub-state machine using the default values ​​of corresponding subsets of multiple variables. The subsets of multiple variables can be updated periodically during the execution of the corresponding sub-state machine.

[0091] At block 306, the control system suspends cell manufacturing based on the detection of an event (e.g., an interruption event). Events may include, but are not limited to, sensor malfunction detection, overcurrent detection, power outage, user-initiated termination, etc. The control system may instruct the biological processing system 10 to retain its current state and / or enter a safe mode. For example, as mentioned above, the manufacturing of cells for cell therapy can take a significant amount of time. Furthermore, individuals undergoing cell therapy (e.g., patients) may have certain diseases. For example, CAR T-cell therapy can be used to treat a patient's cancer diagnosis. Therefore, delaying or restarting the manufacturing of cells for cell therapy may be neither practical nor feasible. Therefore, the control system may use process 300 to suspend and resume cell manufacturing to ensure that cells are not lost due to events. For example, at block 306, the control system may suspend cell manufacturing to retain the current state of the cells. Additionally and / or alternatively, during one or more processes, the control system may not be able to completely suspend the process without damaging the cells or cell structure. Therefore, the control system may set the biological processing system 10 to a safe mode to retain the cell's condition.

[0092] In some variations, the control system may detect events based on notifications (e.g., alarms) received from the biological treatment system 10 (e.g., via user input) and / or by identifying abnormal states in the biological treatment system 10.

[0093] In some examples, the control system may provide one or more first commands to one or more devices / modules within the biological processing system to initiate a safety mode. The safety mode is described in further detail below.

[0094] At block 308, the control system receives user input instructing the manufacture of cells to be resumed and retrieves saved states from external system 20. Saved states can be the last saved state (e.g., the most recently saved state) in external system 20 corresponding to the manufacturing process. For example, as previously mentioned, external system 20 may store multiple states associated with sub-state machines and / or subroutines executed by the control system / biological processing system 10. For example, external system 20 may have stored the following states: state ID "1000" for sub-state machine 202 with protocol ID P301; state ID "2000" for sub-state machine 206 with protocol ID P704; state ID "3000" for sub-state machine 208 with protocol ID P750; and state ID "1100" for sub-state machine 216 with protocol ID P754. The control system can determine the last saved state saved to external system 20 (e.g., a saved state with metadata indicating a timestamp closest to the current time). As previously mentioned, the last saved state can be the state ID associated with the sub-state machine most recently completed by the biological processing system 10 within state machine 200. Additionally and / or alternatively, the last saved state can be the currently executing state and / or the next state to be executed.

[0095] For example, in some cases, the control system may inform the user (e.g., an operator) of the recoverable state machine / sub-state machine associated with the manufacturing process based on a retrieved call stack, for example, displayed on a graphical user interface on a display associated with the control system. Once the user selects to recover the state machine / sub-state machine, the control system can continue executing the recovery process.

[0096] In some examples, the control system may retrieve all or part of the saved states from the call stack of the external system 20. The control system may traverse the retrieved states based on the connections between states as indicated by the decision tree of the state machine 200 or the corresponding sub-state machine.

[0097] In some cases, the control system may store multiple states in another suitable storage device and / or system (e.g., execution block 304) in various suitable use cases, and subsequently retrieve the states from it (e.g., execution block 308). For example, the storage device / system may be integrated into or communicate with the control system / biological processing system 10 (or biological processing system 30).

[0098] At block 310, the control system compares the saved state with the state machine to determine from one or more first sub-state machines the most recently executed sub-state machine by the biological processing system 10 before pausing cell manufacturing. For example, the control system may compare the retrieved saved state from block 308 (e.g., state ID "1100", for sub-state machine 216 with protocol ID P754) with the state machine (e.g., state machine 200) to determine the most recently executed state in the corresponding sub-state machine. For example, as previously mentioned, the call stack may store multiple unique state IDs for the corresponding sub-state machines. The control system may compare the saved state retrieved from the call stack (e.g., with a unique state ID and / or corresponding protocol ID) with state machine 200 to determine the most recently executed sub-state machine. For example, based on the retrieved state ID "1100" and its corresponding protocol ID, the control system may determine that the most recently executed state is sub-state machine P754 in node 216—bag into container. Additionally and / or alternatively, the retrieved state ID “1100” can indicate the next state to be executed, so the control system can determine that the most recently executed state is in the sub-state machine P750-Reagent in node 208.

[0099] In other words, in some examples, based on the last saved state, the control system can determine the interrupted sub-state machine and / or the interrupted state therein, and can determine how to recover the biological processing system 10 based on that determination. For example, the control system can determine the necessary steps / processes to recover the biological processing system 10 / 30 from the determined last state, such as by providing instructions to the biological processing system 10 or 30 to achieve certain conditions, variables, and / or parameters so as to be able to recover the previously interrupted sub-state machine.

[0100] In some examples, the control system may determine one or more first sub-state machines based on the previous execution chain, and then sequentially and systematically check the state information (e.g., state ID) associated with each sub-state machine to determine whether the corresponding sub-state machine completed normally or was interrupted (this will refer to...). Figure 6 (Detailed explanation follows).

[0101] At block 312, the control system resumes cell manufacturing based on the determined sub-state machine. For example, the control system may resume normal state machine execution from an interrupted state within the determined sub-state machine. In some variations, the control system may resume cell manufacturing based on a subset of multiple variables associated with the determined sub-state machine. For example, the control system may provide instructions to set the biological processing system 10 or 30 to certain conditions based on a subset of variables. Afterward, the control system may resume cell manufacturing.

[0102] In some examples, the control system may determine multiple recovery processes based on a defined sub-state machine and control the biological processing system 10 / 30 to execute these multiple recovery processes. Subsequently, the control system may execute subsequent sub-state machines from the multiple sub-state machines to resume cell production.

[0103] In another example, the biological processing system 10 can enter a safe mode upon interruption, unless a power failure prevents the safe mode from being implemented. When the biological processing system 10 enters the safe mode, the control system can provide one or more second instructions to one or more devices / modules within the biological processing system 10 based on a determined sub-state machine to stop the safe mode. The control system can then resume cell manufacturing after the biological processing system 10 exits the safe mode.

[0104] Figure 4 This is an exemplary workflow with interruption events, based on one or more examples of this disclosure. For example... Figures 1A to 1C As illustrated, the control system controls the biological processing system 10 / 30 and the external system 20 to execute workflow 400. Exemplary blocks 402-412 can constitute a connected sequence of sub-state machines in state machine 200, such as... Figure 2 As described in the text. The control system can perform... Figure 3 The process 300 shown in the example executes workflow 400. Figure 4 The descriptions, examples, and procedures described are merely exemplary, and workflow 400 may use other descriptions, examples, and procedures to recover the biological processing system from an interruption event.

[0105] like Figure 4 As shown in the example, the control system is configured to control the biological processing system 10 to sequentially execute blocks 402-412 for the manufacturing process according to workflow 400.

[0106] During operation, the biological treatment system 10 (e.g., its control system) successfully executes the sub-state machines for "opening the path" (in block 402), "starting the pump" (in block 404), and "infusing the tubing" (in block 406). However, when the biological treatment system 10 engages in the sub-state machine "liquid transfer" (in block 408), an interruption 420 occurs. Therefore, the biological treatment system 10 exits the sub-state machine in block 408 and transitions to a safe mode (in block 422). For example, referring to the above, the first sub-state machine may include blocks 402, 404, and 406. Furthermore, the control system may store the states associated with the first sub-state machine blocks 402, 404, and 406 in the external system 20. The last saved state may be a unique state ID associated with the "infusing the tubing" sub-state machine of block 406. When interruption 420 occurs (e.g., an event), the control system provides instructions to guide the biological treatment system 10 into a safe mode (e.g., block 422).

[0107] Once a recovery instruction is received (e.g., a user selection from block 424), the control system can resume the manufacturing process in multiple stages. As indicated in block 426, recovery initialization can be performed first. Recovery initialization refers to the initial stage that may involve several recovery processes to serve as the preliminary recovery process. Upon completion of the initial stage, the control system can cause a downtime pop-up window to be displayed in the user interface (in block 428) and continue to restart the route according to the recovery strategy (in block 430). Therefore, Figure 3 Blocks 308, 310, and 312 may refer to blocks 424, 426, 428, and / or block 430, and the control system can execute recovery strategies and resume cell manufacturing.

[0108] Figure 5 It is a simplified block diagram depicting an exemplary recovery process that occurs after the user selects recovery (in block 424) and before the exemplary downtime pop-up window is displayed (in block 428).

[0109] like Figure 5As shown, after receiving user input (in block 424), the control system can determine a series of processes 500 to be executed by the biological treatment system 10 (or biological treatment system 30) (e.g., corresponding to a sequence of sub-state machines and / or a series of states within the sub-state machines), including restarting environmental controls (in block 502), resetting the graphical user interface (GUI) (in block 504), resetting [unspecified function] (in block 506), resetting the kit (in blocks 508 and 510), and closing and locking the drawer (in block 512). Some processes (such as those in blocks 502, 504, 506, 510, or 512) can be automated. In some variations, the control system can prompt the user to participate in one or more processes. For example, in block 508, the control system can present kit installation instructions, prompting the user to check or reconfigure the kit.

[0110] For example, return to reference Figure 3 And blocks 310 and 312, after determining the most recently executed sub-state machine, allow the control system to resume cell manufacturing. To resume this cell manufacturing, the control system may determine a series of processes to be executed (e.g., process 500) in order to safely restart the manufacturing process (e.g., initiate the cell manufacturing process without damaging, destroying, and / or otherwise altering the cells within the biological processing system 10).

[0111] After the recovery process is complete, the control system can execute block 428, presenting an example downtime pop-up window 520. For example... Figure 5 As shown, the downtime pop-up window 520 can indicate that recovery is in progress. Additionally, the downtime pop-up window may include information indicating the duration of the system's downtime and / or an estimated countdown until recovery is complete.

[0112] At block 430, the control system can restart the route based on a recovery strategy. For example, the control system can perform actions such as... Figure 3 The illustrated process 300 determines the most recently executed sub-state machine (e.g., corresponding to the process "liquid transfer" in block 408) before suspending the manufacturing process. Additionally, the control system can determine that blocks 402, 404, and 406 are mandatory before executing block 408. Therefore, the control system can restart the biological processing system 10 by resuming at block 402 (e.g., "open path"). Similarly, if an interruption occurs during blocks 402, 404, or 406, the control system can restart the biological processing system 10 by resuming at block 402. In some scenarios, if an interruption occurs during blocks 410 or 412, the control system can restart the biological processing system 10 at block 410 ("stop pump") or block 412 ("close path"), respectively.

[0113] In essence, for certain application crash points (e.g., the point where an event occurs and the manufacturing process must be paused), the application's execution can be restarted from its last executed state (e.g., from...). Figure 4 The application can resume execution from the "Stop Pump" state (block 410). In some scenarios, application execution can resume from a previous execution state (e.g., from...). Figure 4 The system can recover from the "open path" state (block 402). For example, the control system can execute a specific process according to predefined rules to recover the application from another "recovery point". For example, when the control system determines that the crash point is a specific state and / or within a specific sub-state machine, the control system can determine a target state within the target sub-state machine for the application to recover from. In some cases, the system can perform additional recovery steps before recovering the system (e.g., after the downtime pop-up in block 428 and before restarting the route in block 430). For example, if an interruption occurs during a state "injection" (e.g., with protocol ID P762) within a sub-state machine, an additional step involving cell sedimentation is performed after the downtime pop-up (in block 428). This cell sedimentation step may not be included in sub-state machine P762. However, this step is performed during the recovery process. The following examples of processes that can be performed by the control system are provided for illustrative purposes only, and certain scenarios are depicted for ease of understanding.

[0114] refer to Figure 2 The application can be interrupted while executing sub-state machine P701 (in block 204, “Kit Test”). During recovery, based on the determination that the last executed sub-state machine was P701 (e.g., any state within that sub-state machine), the control system can restore the application's state machine 200 to the initial state of sub-state machine P701. Therefore, after recovery, the application can restart the execution of sub-state machine P701 from the beginning.

[0115] The application can be interrupted while executing sub-state machine P702 (in block 222 "Volume Reduction"). Based on the interrupted state within this sub-state machine P702, the control system can determine different recovery points for the application. For example, if the interrupted state is related to a settling phase, such as when the biological treatment system 10 is interrupted during the settling time, the control system can restore the application's state machine 200 from a recovery point prior to the interrupted state, so that the restored application will redo the settling time.

[0116] The application can be interrupted while executing sub-state machine P703 (in block 224 "Washing"). Similarly, if the interrupted state is one of the "Settling" state, "Boost" state, or "Culture and Waste Bag Quality Check Before Washing" state within sub-state machine P703, the control system can restore the application's state machine 200 from the recovery point prior to the interrupted state, allowing the restored application to redo the interrupted state from scratch. Alternatively and / or additionally, the control system can restore the interrupted sub-state machine based on user input. For example, if the interrupted state is the "Infuse" state, the control system can query the user for an optional settling period and continue with the remaining washing duration.

[0117] Similarly, if the application is interrupted while executing the "feeding" sub-state machine, the control system can query the user for an optional settling period and restart the feeding period upon resumption.

[0118] The application can be interrupted while executing the "bag installation" sub-state machine. For example, if the interrupted state occurs during bag installation instructions, the control system can determine to redo those instructions upon resumption.

[0119] In the sub-state machine of "container mixing", if the interrupted state is during constant container (CV) mixing, the control system can determine to redo the CV mixing upon recovery.

[0120] In the sub-state machine of "cell bag mixing", if the interrupted state occurs during mixing, the control system can provide instructions to the user to redo the mixing upon resumption.

[0121] In substate machine P752 "Clear Pipeline" (e.g., in blocks 212, 218, or 220), if the interrupted state is related to any point during pipeline clearing, the control system can resume the application to perform pipeline clearing from the beginning.

[0122] In the sub-state machine associated with any of the container-to-bag, bag-to-container, bag-to-bag, or container-to-container transfers (e.g., in block 216), if the interrupted state occurs during a liquid transfer, the control system can resume the application to restart and transfer the remaining mass.

[0123] In the "sampling" sub-state machine, if the interrupted state occurs during the sampling process, the control system can resume the application to restart sampling from the beginning.

[0124] In the "feed" sub-state machine, if the interrupted state occurs during a user-initiated push, the control system can resume the application to restart the user-initiated sequence. Essentially, if an interruption occurs during a user-initiated sequence, particularly within a user command sequence, the control system can restart the application from the beginning of the sequence.

[0125] In the sub-state machine of "small volume addition (syringe)," if the interrupted state is before filling, the control system can resume the application to restart small volume addition (syringe) from scratch.

[0126] In the "culture dispensing" sub-state machine, if the interrupted state occurs during a user prompt for dispensing, the control system can resume the application to restart the user prompt sequence.

[0127] Figure 6 This is an exemplary workflow for restoring a state machine according to one or more examples of this disclosure. For example... Figures 1A to 1C As illustrated, the control system controls the biological processing system 10 / 30 and the external system 20 to execute workflow 600. Exemplary blocks involved in workflow 600 may be exemplary implementations of the control system executing portions of state machine 200 when encountering events, such as... Figure 2 As described in the text. The control system can perform... Figure 3 The process 300 shown in the example executes workflow 600. Figure 6 The descriptions, examples, and procedures described are merely exemplary, and workflow 600 may use other descriptions, examples, and procedures to recover the biological processing system from an interruption event.

[0128] In this example, the control system is configured to execute a series of sub-state machines within state machine 200, such as Figure 2 Described in: P301 202 P704 206 P750 208 P754 216. During operation, the control system has stored in external system 20 a call stack with corresponding executed states: state ID "1000", for sub-state machine P301; state ID "2000", for sub-state machine P704; state ID "3000", for sub-state machine P750; state ID "1100", for sub-state machine P754. Additionally and / or alternatively, the control system has saved all variables associated with the executed sub-state machines corresponding to the call stack. In the event of a crash, the last values ​​of the variables for all sub-state machines used in a specific application (APP) are retrievable.

[0129] Under normal operating conditions, when the control system executes a sub-state machine within state machine 200, the control system can use default values ​​to configure the biological treatment system 10 for initiating the sub-state machine. During the execution of the sub-state machine, the control system can retain variable values ​​through sub-state machine callbacks.

[0130] In this example, at block 602, the control system loads the state machine associated with the selected application (e.g., with root node 202 corresponding to sub-state machine P301).

[0131] At block 604, the control system determines whether the application's previous operation has been aborted.

[0132] Based on the confirmation that the previous operation was not interrupted, at block 606, the control system loads the default variable values ​​corresponding to sub-state machine P301. At block 608, the control system stores the first state corresponding to sub-state machine P301 in an appropriate form to external system 20. For example, the first state and / or the corresponding sub-state machine (P301) can be stored in Extensible Markup Language (XML) code. The control system can include additional information, such as variable values ​​corresponding to the sub-state machine and / or state, in the saved XML code. At block 610, the control system starts executing the applied state machine from the first state corresponding to sub-state machine P301.

[0133] At block 612, based on the determination that the previous operation was aborted, the control system prompts the user to choose whether to resume the application. If the user chooses not to resume the application, the control system can proceed to block 606 to restart the application.

[0134] When the user selects to restore the application, the control system proceeds to block 620 to restore the application according to the restoration strategy outlined in blocks 620, 622, 624, 626, 628, and 630. In this example, the last state ID refers to the state ID last saved to the corresponding sub-state machine. For example, the last state ID can be saved to the completed state within the corresponding sub-state machine. Alternatively, the last state ID can be saved for the interrupted state within the corresponding sub-state machine after an interruption occurs.

[0135] At block 620, the control system loads the last state ID and saved variable values ​​of sub-state machine P301.

[0136] At block 622, the control system determines whether the crash state in P301 is a sub-state machine caller state. For example, the control system may determine whether a subsequent sub-state machine within state machine 200 will be executed after P301 based on the last state ID of sub-state machine P301. The control system may make decisions based on the last state ID of P301 and / or saved variables.

[0137] If not, the control system instructs the state machine to continue normal execution.

[0138] At block 624, based on the determination in P301 that the crash state is the sub-state machine caller state, the control system calls sub-state machine P704. Then, at block 626, the control system loads the last state ID (or other suitable state ID) and saved variable values ​​associated with sub-state machine P704 from external system 20.

[0139] At block 628, the control system determines whether the crash state in P704 is a sub-state machine caller state. The control system may make a decision based on the last state ID and / or saved variables of P704. If not, the control system instructs the state machine to continue normal execution. If so, the control system may execute additional blocks similar to blocks 624 and 626. These blocks have been omitted from workflow 600 for simplicity only. When present and similar to blocks 626 and 626, the control system calls the next sub-state machine (e.g., P750) and loads the last state ID and saved variable values ​​associated with sub-state machine P750 from external system 20. The control system may then determine whether the crash state in P750 is a sub-state machine caller state, and this may be repeated up to block 630.

[0140] At block 630, the control system determines in P754 whether the crash state is a sub-state machine caller state. The control system may repeat a similar process until it identifies the "last level" sub-state machine associated with the crash state. Thus, saved values ​​(such as the last state ID and / or saved variable values) are loaded until execution is directed to the last level sub-state machine where the interruption occurred. For example, based on the control system's determination that the crash state is associated with sub-state machine 754, the control system directs the state machine to continue execution as normal from the last level sub-state machine (in block 610).

[0141] Figure 7 This is an exemplary workflow for resuming a manufacturing process according to one or more examples of this disclosure. For example... Figures 1A to 1C As illustrated, the control system controls the biological treatment system 10 / 30 and the external system 20 to execute workflow 700. Exemplary processes involved in workflow 700 may be exemplary implementations of portions of paths in the control system's execution state machine 200, such as... Figure 2 As described in the text. The control system can perform... Figure 3 The process 300 shown in the example executes workflow 700. Figure 7 The descriptions, examples, and procedures described are merely exemplary, and workflow 700 may use other descriptions, examples, and procedures to recover the biological processing system from an interruption event.

[0142] For example, the control system may execute workflow 700 to determine whether to put the bioprocessing system 10 into a safe mode. At block 702, the control system runs an application (APP) to control the manufacturing process on the bioprocessing system 10. During operation, the control system stores relevant information in external system 20, including a state ID (e.g., a last saved state ID), a set of variables, and / or other appropriate information corresponding to each sub-state machine in the application. Operation is aborted.

[0143] At block 704, the control system can determine the cause of the failure and then decide on the appropriate course of action for suspending the biological processing system 10. For example, the control system can identify whether a user pressed the emergency button or a hardware (HW) error aborted operation. To this end, the biological processing system 10 can enter a safe mode after the interruption (e.g., the software (SW) safe mode at block 706). In safe mode, the biological processing system 10 can maintain certain conditions to preserve the samples in the system. For example, the biological processing system 10 can perform operations such as maintaining the temperature and carbon dioxide (CO2) level within the system, closing all pinch valves (PV), stopping the pump, restoring the tilt platform to a horizontal position, engaging disposable kits (DK), activating red lights (e.g., red light-emitting diodes (LEDs)), or disengaging interlocking devices.

[0144] Alternatively, the control system may experience an abnormal shutdown (e.g., a power outage). When power is restored, the engagement and pinch valve manifold (PVM) within the biological treatment system 10 may be in the same state as before shutdown (at block 708). The control system may restore the software (SW) on the biological treatment system 10, which may cause operations such as restarting temperature or CO2 control, closing all PVs, activating red lights, or opening interlock devices (at block 710).

[0145] Subsequently, the control system can determine whether and how to resume the application based on user input. As explained below, the control system can provide the user with various available options at different stages to select the appropriate course of action.

[0146] When the biological processing system 10 is in SW safe mode, the control system can prompt the user to confirm whether to restore the application or return to the menu (at block 712).

[0147] If the user chooses to restore the application (APP), the control system can perform actions such as Figure 3 The process shown in step 300 is to restore the application and then continue the application (at block 740). In some cases, the control system may perform the recovery in multiple stages, such as... Figure 4 and Figure 5 As described in the text. By executing the recovery process, the control system can instruct the corresponding state machine to continue its interrupted application, such as... Figure 6As shown in the image.

[0148] If the user chooses not to resume at this time, the control system can navigate to the APP menu to re-initiate the hardware (at block 714). Re-initiating HW can involve operations such as stopping temperature control, disengaging from DK, turning on all PVs, or activating green lights (e.g., green LEDs). The user can then fix the problem and instruct the control system to load the application.

[0149] At this point, the control system can determine whether the same application has been loaded (at block 716). If the control system determines that the loaded application is different from the aborted application, the recovery point (e.g., the recovery point) may be lost (at block 718). Otherwise, if the same application has been loaded, the control system can prompt the user to choose between initiating a normal start of the application (indicating no recovery) (at block 722) or recovering and continuing the application (at block 740).

[0150] Referring back to the abnormal shutdown from block 704, when the biological processing system 10 restarts after an abnormal shutdown, after user login (at block 724), the control system can execute block 712 and guide the user through the same decision path discussed above (from block 714). Alternatively, if the user chooses to restore the APP, the control system can execute as follows... Figure 3 The process shown in step 300 is to restore the app and then continue the app (at block 740).

[0151] Figure 8A An exemplary environment according to examples of this disclosure is depicted. Entities within environment 800 may take the form of any suitable system described herein and are configured to perform the processes and workflows outlined herein.

[0152] like Figure 8A As shown, environment 800 includes a first biological processing system 810, a second biological processing system 820, and a central historical record service 830 operating on a cloud platform. These components are interconnected via a network, thereby facilitating communication between the first biological processing system 810 and the second biological processing system 820. Each biological processing system can be controlled by a corresponding control system within or connected to that system to control its operation.

[0153] In this example, the control system controls the first biological processing system 810 to send relevant data to the central historical record service 830, thereby facilitating the recovery of applications on the biological processing system using the stored data. For example, the first biological processing system 810 may perform real-time backups and / or on-demand backups. In the case of recovering applications on the second biological processing system 820, the control system controls the second biological processing system 820 to perform on-demand recovery. For example, the control system retrieves saved data from the central historical record service 830 and configures the second biological processing system 820 to recover processes from the first biological processing system 810.

[0154] Figure 8B It is for reference. Figure 8A An exemplary workflow for restoring an application. For example... Figure 8A As shown, based on relevant data retrieved from the historical data service 830, an application interrupted on equipment A 810 is resumed on equipment B 820. Workflow 850 can be executed by the control system of equipment A and / or the control system of equipment B. A user (e.g., operator 802) can instruct the control system to execute workflow 850 to resume the application on equipment B.

[0155] At block 852, operator 802 initiates the application on equipment A 810.

[0156] At block 854, during normal operation, device A 810 continuously uploads application-related data, such as parameters, variables, and states, to the historical record service 830. The stored data of device A 810 can be referred to as device A application backup.

[0157] At block 856, in the event of an interruption, equipment A 810 sends a notification to operator 802 indicating that the application has failed.

[0158] At block 858, operator 802 requests equipment B 820 to restore the application on equipment A 810.

[0159] At block 860, device B 820 requests a backup of device A's application from the history service 830.

[0160] At block 862, equipment B 820 restores the backup of equipment A application from the history service 830.

[0161] At block 864, device B sends a notification to the operator instructing the restoration of device A's application on device B 820.

[0162] At block 866, operator 802 instructs equipment B 820 to resume the interrupted application.

[0163] Upon receiving a recovery command from operator 802, the control system of equipment B 820 may execute process 300 and / or other suitable workflows disclosed herein to perform the recovery of the application on equipment B 820.

[0164] Figure 9A An exemplary environment according to examples of this disclosure is depicted. Entities within environment 900 may take the form of any suitable system described herein and are configured to perform the processes and workflows outlined herein.

[0165] With Figure 8A Similar to the environment 800 depicted, environment 900 includes a first biological treatment system 810 and a second biological treatment system 820. Figure 8A Unlike the environment 800 shown, in this example environment 900, an external storage device 930 (such as a USB device) is used to restore necessary information, thereby facilitating application backup. Each biological processing system can be controlled by a corresponding control system within or connected to that system to control its operation.

[0166] The external storage device 930 is first connected to the first biological processing system 810. The first biological processing system 810 can perform real-time backup and / or on-demand backup when connected to the external storage device 930.

[0167] Following an interruption event, the user may decide to resume the interrupted application on the second biological processing system 820. To do this, the user can disconnect the external storage device 930 from the first biological processing system 810 and then connect the external storage device to the second biological processing system 820. To resume the application on the second biological processing system 820, the control system controls the second biological processing system 820 to perform on-demand recovery. For example, the control system retrieves saved data from the external storage device 930 and configures the second biological processing system 820 to resume the process on the first biological processing system 810.

[0168] Figure 9B It is for reference. Figure 9A An exemplary workflow for restoring an application. For example... Figure 9A As shown, based on relevant data retrieved from the USB flash drive 930, the application interrupted on device A 810 is resumed on device B 820. Workflow 950 can be executed by the control system of device A and / or the control system of device B. A user (e.g., operator 902) can instruct the control system to execute workflow 950 to resume the application on device B.

[0169] At block 952, operator 902 initiates the application on device A 810. In some examples, device A 810 may continuously store relevant data associated with the application (such as parameters, variables, and states) in USB flash drive 930 during normal operation. The stored data on device A 810 may be referred to as a backup of the device A application.

[0170] At block 954, in the event of an interruption, equipment A 810 sends a notification to operator 902 indicating that the application has failed.

[0171] At block 956, operator 902 requests equipment A 810 to store a backup in a USB flash drive. The backup may be referred to as equipment A application backup.

[0172] At block 958, device A 810 stores a backup of device A application in USB flash drive 930.

[0173] At block 960, operator 902 requests equipment B 820 to restore equipment A application backup.

[0174] At block 962, device B 820 requests device A application backup from USB flash drive 930.

[0175] At block 964, device B 820 restores device A application backup from USB flash drive 930.

[0176] At block 966, device B 820 sends a notification to operator 902 instructing to restore the backup of device A application on device B 820.

[0177] At block 968, operator 902 instructs equipment B 820 to resume the interrupted application.

[0178] Upon receiving a recovery command from the operator, the control system of equipment B 820 may execute process 300 and / or other suitable workflows disclosed herein to perform the recovery of the application on equipment B 820.

[0179] Many embodiments have been described. However, it should be understood that additional modifications may be made without departing from the scope of the inventive concept described herein, and thus other examples are within the scope of the appended claims. For example, it should be understood that the examples of applications described herein are merely exemplary. Variations of these examples will become apparent to those skilled in the art after reading the foregoing description. The inventors expect those skilled in the art to appropriately employ such variations, and the inventors intend for this application to be practiced in ways other than those explicitly described herein. Therefore, this application includes all modifications and equivalents of the subject matter set forth in the appended claims to the extent permitted by applicable law. Furthermore, unless otherwise indicated herein or otherwise clearly contradicted by the context, this application covers any combination of the foregoing elements in all possible variations.

[0180] Those skilled in the art will also understand that the execution of the various machine-implemented processes and steps described herein can be performed via computerized execution of processor-executable instructions stored on a non-transitory computer-readable medium, such as random access memory (RAM), read-only memory (ROM), programmable read-only memory (PROM), volatile, non-volatile, or other electronic storage mechanisms. Thus, for example, operations described herein as being performed by a computing device and / or its components can be performed according to processor-executable instructions and / or installed applications corresponding to software, firmware, and / or computer hardware.

[0181] The use of the term "at least one" followed by a list of one or more items (e.g., "at least one of A and B") should be understood to mean one item selected from the listed items (A or B) or any combination of two or more of the listed items (A and B), unless otherwise specified herein or obviously contradicted by the context. Unless otherwise specified, the terms "comprising," "having," "including," and "containing" should be understood as open-ended terms (i.e., meaning "including but not limited to"). Unless otherwise specified herein, the description of numerical ranges herein is intended only as a shorthand method of individually referring to each individual value falling within that range, and each individual value is incorporated into this specification as if it were individually described herein. Unless otherwise specified herein or otherwise obviously contradicted by the context, all methods described herein can be performed in any suitable order. Unless otherwise stated, the use of any and all embodiments or exemplary language (e.g., "such as") provided herein is intended only to better illustrate the application and does not constitute a limitation on the scope of the application. No language in the specification should be construed as indicating that any element not protected by the claims is essential to the practice of this application.

Claims

1. A method for restoring a biological processing system configured to manufacture cells for cell therapy, the method comprising: One or more processors and the biological processing system execute one or more first sub-state machines of a plurality of sub-state machines for manufacturing the cells, wherein each of the plurality of sub-state machines is associated with a node within a state machine, wherein the state machine includes a decision tree with multiple branches and multiple nodes; Multiple states are stored in an external system by the one or more processors, wherein each of the multiple states is saved to the external system based on the completion of a state within a first sub-state machine for manufacturing the cell from the one or more first sub-state machines; Based on the detected event, the manufacturing of the cell is paused by the one or more processors; Based on user input received instructing the restoration of the cell manufacturing process, the one or more processors retrieve a saved state from the external system, wherein the saved state is the last state saved to the external system; The one or more processors compare the saved state with the state machine to determine from the one or more first sub-state machines the sub-state machine most recently executed by the biological processing system before the cell manufacturing was suspended; as well as The manufacturing of the cell is recovered by the one or more processors based on the determined sub-state machine.

2. The method of claim 1, wherein each of the plurality of states stored in the external system is associated with a state identifier (ID), and wherein comparing the saved states with the state machine to determine the sub-state machine comprises: The state ID of the saved state is compared with the state machine to determine the sub-state machine from the plurality of sub-state machines that has the same state ID as the saved state; as well as The sub-state machine is determined based on the comparison results.

3. The method of claim 1, further comprising: Multiple variables associated with the operating conditions of the biological processing system are stored by the one or more processors in the external system, wherein a subset of the multiple variables is saved to the external system based on the completion of the sub-state machine for manufacturing the cells from the one or more first sub-state machines. The restoration of the cell manufacturing process is further based on the use of a subset of the plurality of variables associated with the determined sub-state machine.

4. The method of claim 3, wherein execution of the sub-state machine from the one or more first sub-state machines begins with default values ​​of the subset of the plurality of variables, and wherein the subset of the plurality of variables is periodically updated during the execution of the sub-state machine from the one or more first sub-state machines.

5. The method of claim 1, further comprising: Receive multiple first user inputs indicating multiple parameters associated with the manufacture of the cells; as well as The one or more first sub-state machines are determined based on the aforementioned parameters.

6. The method of claim 1, wherein pausing the manufacturing of the cell based on detecting the event comprises: One or more first instructions are provided to one or more devices within the biological processing system to initiate a safe mode, and in The manufacture of the restored cells includes: Based on the determined sub-state machine, one or more second instructions are provided to the one or more devices within the biological processing system to stop the safety mode.

7. The method of claim 6, wherein the biological treatment system maintains certain conditions in the safety mode to preserve the cells within the biological treatment system, and Providing the one or more first instructions to the one or more devices within the biological processing system to initiate the safety mode includes one or more of the following: Maintain the temperature and carbon dioxide (CO2) level within the biological treatment system; Close one or more pinch valves (PV); Stop one or more pumps; Return the tilted platform within the biological treatment system to a horizontal position; Joining disposable kits (DK); Activate the red light; or Open one or more interlocking devices.

8. The method of claim 1, wherein restoring the manufacture of the cells comprises: Multiple recovery processes are determined based on the identified sub-state machines; Perform the aforementioned multiple recovery procedures; as well as After performing the plurality of recovery processes, a subsequent sub-state machine from the plurality of sub-state machines is executed to restore the manufacturing of the cell.

9. The method of claim 1, wherein the external system is a removable storage device.

10. The method of claim 1, wherein the external system is a network attached storage device (NAS), and wherein storing the plurality of states includes providing the plurality of states to the NAS via a network by the one or more processors.

11. The method of claim 1, wherein restoring the manufacturing of the cell based on the determined sub-state machine comprises: Instructions are provided to a second biological processing system to resume the manufacture of the CAR T cells based on a determined sub-state machine, wherein the second biological processing system is separate from the biological processing system executing the one or more first sub-state machines.

12. The method of claim 1, wherein the external system includes a database, and wherein the plurality of states are saved to the database in the external system based on a sequence of completing each of the plurality of sub-state machines.

13. The method of claim 1, wherein the cell therapy is chimeric antigen receptor (CAR) T-cell therapy.

14. A non-transitory computer-readable medium having stored thereon instructions for resuming a biological processing system configured to manufacture cells for cell therapy, wherein the instructions, when executed by one or more processors, cause the one or more processors to perform the following operations: The biological processing system is used to execute one or more first sub-state machines among a plurality of sub-state machines for manufacturing the cells, wherein each of the plurality of sub-state machines is associated with a node within a state machine, wherein the state machine includes a decision tree with multiple branches and multiple nodes; Multiple states are stored in an external system, wherein each of the multiple states is saved to the external system based on the completion of the sub-state machine for manufacturing the cell from the one or more first sub-state machines; Based on the detected event, the manufacturing of the cell is paused; Based on the user input received instructing the restoration of the cell manufacturing process, a saved state is retrieved from the external system, wherein the saved state is the last state saved to the external system; The saved state is compared with the state machine to determine from the one or more first sub-state machines the sub-state machine most recently executed by the biological processing system before the cell manufacturing was paused; as well as The manufacturing of the cell is recovered based on the determined sub-state machine.

15. The non-transitory computer-readable medium of claim 14, wherein each of the plurality of states stored in the external system is associated with a state identifier (ID), and wherein comparing the saved states with the state machine to determine the sub-state machine comprises: The identifier associated with the saved state is compared with the state machine to determine from the plurality of sub-state machines a sub-state machine that has a state ID that is the same as the saved state; as well as The sub-state machine is determined based on the comparison results.

16. The non-transitory computer-readable medium of claim 14, wherein the instructions, when executed by one or more processors, cause the one or more processors to further perform the following operations: Multiple variables associated with the operating conditions of the biological processing system are stored in the external system, wherein a subset of these variables is saved to the external system based on the completion of the sub-state machine for manufacturing the cells from the one or more first sub-state machines. The restoration of the cell manufacturing process is further based on the use of a subset of the plurality of variables associated with the determined sub-state machine.

17. The non-transitory computer-readable medium of claim 16, wherein execution of the sub-state machine begins with default values ​​of the subset of the plurality of variables, and wherein the subset of the plurality of variables is periodically updated during the execution of the sub-state machine from the one or more first sub-state machines.

18. The non-transitory computer-readable medium of claim 14, wherein the instructions, when executed by one or more processors, cause the one or more processors to further perform the following operations: Receive multiple first user inputs indicating multiple parameters associated with the manufacture of the cells; and The one or more first sub-state machines are determined based on the aforementioned parameters.

19. The non-transitory computer-readable medium of claim 14, wherein pausing the manufacturing of the cell based on detecting the event comprises: Providing one or more first instructions to one or more devices within the biological processing system to initiate a safe mode, wherein resuming the manufacturing of the cells comprises: Based on the determined sub-state machine, one or more second instructions are provided to the one or more devices within the biological processing system to stop the safety mode.

20. A system for restoring a biological processing system configured to manufacture cells for cell therapy, the system comprising: A first device, which communicates with one or more processors; and The one or more processors are configured to: The biological processing system is used to execute one or more first sub-state machines of a plurality of sub-state machines for manufacturing the cells, wherein each of the plurality of sub-state machines is associated with a node from a state machine, wherein the state machine includes a decision tree with a plurality of branches and a plurality of nodes; Multiple states are stored in the first device, wherein each of the multiple states is saved to the first device based on the completion of the sub-state machine for manufacturing the cell from the one or more first sub-state machines; Based on the detected event, the manufacturing of the cell is paused; Based on receiving user input instructing the restoration of the cell manufacturing process, a saved state is retrieved from the first device, wherein the saved state is the last state saved to the first device; The saved state is compared with the state machine to determine from the one or more first sub-state machines the sub-state machine most recently executed by the biological processing system before the cell manufacturing was paused; as well as The manufacturing of the cell is recovered based on the determined sub-state machine.